Sort
172,184 grants matching “inflammation”
PET Radiopharmaceutical Sciences
$4,011,506Victor W Pike · National Institute Of Mental Health · ZIA · FY2010 · MH
Bioanalysis, Drug Metabolism and New Drug Discovery
$4,004,627Josephine Egan · National Institute On Aging · ZIA · FY2024 · AG
Program in Clinical Research, Clinical Support Services and Clinical Training
$4,004,212Stavros Garantziotis · National Institute Of Environmental Health Sciences · ZID · FY2018 · ES
Microglial apoE in neuroinflammation and Alzheimer's disease
$4,000,570John David Fryer · Mayo Clinic Arizona · RF1 · FY2019 · AG
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$3,999,997Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2015 · HL
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$3,999,997Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2017 · HL
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$3,999,997Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2014 · HL
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$3,999,997Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2016 · HL
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$3,999,996Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2013 · HL
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research
$3,995,473Steven M Wolinsky · Northwestern University At Chicago · U01 · FY2020 · HL
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis
$3,993,521James Dale Berry · Massachusetts General Hospital · U01 · FY2025 · NS
Multicenter AIDS Cohort Study
$3,988,665John P Phair · Howard Brown Health Center · U01 · FY2009 · AI
Vanderbilt-coordinated human Virome Collaborative Center (V2C2)
$3,984,525Suman Ranjan Das · Vanderbilt University Medical Center · U54 · FY2025 · AG
Genotypic Determinants of Aspirin Response in High-Risk
$3,980,607Johns Hopkins University · U01 · FY2003 · HL
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression
$3,976,480Prescott G Woodruff · University Of California, San Francisco · U01 · FY2020 · HL
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)
$3,974,247Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2021 · HL
Risk Factors for Incident Alzheimer's Disease in a Biracial Community
$3,967,194Denis A Evans · Rush University Medical Center · R01 · FY2009 · AG
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$3,963,391Ignacio E. Sanz · Emory University · U54 · FY2020 · CA
International Case Control Study of Malignant Glioma
$3,962,501Melissa L Bondy · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Center on Proteolytic Pathways(RMI)
$3,960,022Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · U54 · FY2006 · RR
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center
$3,958,451Joseph B. Margolick · Johns Hopkins University · U01 · FY2025 · HL
Disease Status Drug Metabolism and New Drug Discovery
$3,957,647Irving William Wainer · National Institute On Aging · ZIA · FY2014 · AG
Examination Of Natural History And Therapy Of Multiple Sclerosis Using MRI
$3,957,485Henry F McFarland · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
University of Washington/Fred Hutch Center for AIDS Research
$3,946,565Connie L Celum · University Of Washington · P30 · FY2023 · AI
Procurement and Characterization of Postmortem Brain Tissue
$3,942,053Stefano Marenco · National Institute Of Mental Health · ZIC · FY2025 · MH